These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33193697)

  • 21. Inhibition of the cell migration, invasion and chemoresistance of colorectal cancer cells through targeting KLF3 by miR-365a-3p.
    Li J; Mo R; Zheng L
    J Cancer; 2021; 12(20):6155-6164. PubMed ID: 34539888
    [No Abstract]   [Full Text] [Related]  

  • 22. CircCSNK1G1 Contributes to the Development of Colorectal Cancer by Increasing the Expression of MYO6 via Competitively Targeting miR-455-3p.
    Huang X; Shen X; Peng L; Mai W; Wan Y; Zhang H
    Cancer Manag Res; 2020; 12():9563-9575. PubMed ID: 33061642
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Hu B; Xian Z; Zou Q; Zhang D; Su D; Yao J; Ren D
    Cancer Biother Radiopharm; 2021 Feb; 36(1):45-57. PubMed ID: 32379550
    [No Abstract]   [Full Text] [Related]  

  • 24. LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p.
    Li M; Bian Z; Jin G; Zhang J; Yao S; Feng Y; Wang X; Yin Y; Fei B; You Q; Huang Z
    Cancer Med; 2019 May; 8(5):2404-2413. PubMed ID: 30945457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
    Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
    J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
    Si Z; Yu L; Jing H; Wu L; Wang X
    J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circ_0087862 promotes the progression of colorectal cancer by sponging miR-142-3p and up-regulating BACH1 expression.
    Huang B; Cui DJ; Yan F; Yang LC; Zhang MM; Zhao X
    Kaohsiung J Med Sci; 2021 Dec; 37(12):1048-1057. PubMed ID: 34390174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SNHG4 promotes malignant biological behaviors and immune escape of colorectal cancer cells by regulating the miR-144-3p/MET axis.
    Zhou N; Chen Y; Yang L; Xu T; Wang F; Chen L; Liu J; Liu G
    Am J Transl Res; 2021; 13(10):11144-11161. PubMed ID: 34786048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Non-Coding RNA SNHG16 Activates USP22 Expression to Promote Colorectal Cancer Progression by Sponging miR-132-3p.
    He X; Ma J; Zhang M; Cui J; Yang H
    Onco Targets Ther; 2020; 13():4283-4294. PubMed ID: 32547062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Positive Feedback Loop of lncRNA MIR31HG-miR-361-3p -YY1 Accelerates Colorectal Cancer Progression Through Modulating Proliferation, Angiogenesis, and Glycolysis.
    Guo T; Liu D; Peng S; Wang M; Li Y
    Front Oncol; 2021; 11():684984. PubMed ID: 34485123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDAC3 deteriorates colorectal cancer progression via microRNA-296-3p/TGIF1/TGFβ axis.
    Li J; Hu M; Liu N; Li H; Yu Z; Yan Q; Zhou M; Wang Y; Song Y; Pan G; Liang F; Chen R
    J Exp Clin Cancer Res; 2020 Nov; 39(1):248. PubMed ID: 33203425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells.
    Almeida MI; Nicoloso MS; Zeng L; Ivan C; Spizzo R; Gafà R; Xiao L; Zhang X; Vannini I; Fanini F; Fabbri M; Lanza G; Reis RM; Zweidler-McKay PA; Calin GA
    Gastroenterology; 2012 Apr; 142(4):886-896.e9. PubMed ID: 22240480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of visfatin in promoting proliferation and invasion of colorectal cancer cells by downregulating SDF-1/CXCR4-mediated miR-140-3p expression.
    Zhao Q; Li JY; Zhang J; Long YX; Li YJ; Guo XD; Wei MN; Liu WJ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5367-5377. PubMed ID: 32495871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling.
    Sun N; Zhang L; Zhang C; Yuan Y
    Cell Mol Biol Lett; 2020; 25():19. PubMed ID: 32206063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Novel lncRNA RP9P Promotes Colorectal Cancer Progression by Modulating miR-133a-3p/FOXQ1 Axis.
    Jin Z; Liu B; Lin B; Yang R; Wu C; Xue W; Zou X; Qian J
    Front Oncol; 2022; 12():843064. PubMed ID: 35600345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10.
    Yang X; Chen J; Liao Y; Huang L; Wen C; Lin M; Li W; Zhu Y; Wu X; Iwamoto A; Wang Z; Liu H
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31763673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
    Li JL; Luo P
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.